If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Avian influenza timeline: From chickens to foxes, here's how bird flu is spreading across the US If successfully developed, Moderna’s mRNA-based pandemic flu vaccine could improve response times ...

A new bird flu vaccine could be on the horizon after the U.S. has invested approximately $590 million to accelerate its development, the Department of Health and Human Services (HHS) announced on ...

A Moderna influenza vaccine for avian influenza, or “bird flu,” will head into a pivotal clinical trial with $176 million in funding from the U.S. federal government.. The funding announced by ...

Massachusetts-based Moderna will likely be the first to manufacture a bird flu vaccine, backed by hundreds of millions in government funding. The biopharmaceutical giant is developing the vaccine ...

Funding from U.S. biodefense agency Barda will support Moderna in developing an mRNA-based pandemic flu vaccine as fears grow the H5N1 outbreak tearing through American ... How Could Avian Flu ...

Shares of Moderna were up 4% in after-hours trading Friday. The government’s recent funding for Moderna’s mRNA bird flu shot now totals $766 million, approaching the $995 million spent on the ...

Moderna has become the latest biopharma to benefit from the U.S. Department of Health and Human Services' concerns about avian flu, awarding the company $176 million to fund the clinical ...

Avian influenza timeline: From chickens to foxes, here's how bird flu is spreading across the US If successfully developed, Moderna’s mRNA-based pandemic flu vaccine could improve response times ...

Funds to develop bird flu vaccine for humans awarded to Moderna amid avian flu outbreak. ... This is a concern with H5N1 avian influenza, even if the current risk to human health remains low.